Els de Gussem, MD
Grace Hospital, Winnipeg MB

Shunting due to pulmonary arteriovenous malformations (AVMs) occurs mainly (80-90%) in persons with Hereditary Hemorrhagic Telangiectasia (HHT). HHT is an underrecognized disorder, affecting 1/7000 persons. During this presentation, management of pulmonary AVMs will be discussed as well as modes of screening for pulmonary AVMs in adults and children and follow-up after treatment of pulmonary AVMs. HHT is an autosomal dominant inherited vascular disorder affecting multiple organs.

Learning Objectives:
At the end of this presentation, attendees will be able to:

  • Know how to screen for the presence of pulmonary AVMs;
  • Know when pulmonary AVMs should be treated and how; and
  • Know how to follow patients after embolotherapy of pulmonary AVMs.

CanMEDS Roles Addressed: Collaborator, Communicator, Health Advocate, Medical Expert